Abstract
We recently found that exogenous angiotensin-(1-7) [Ang-(1-7)] inhibits Angiotensin II (Ang-II)-induced atherosclerotic lesion formation and enhances plaque stability. Our objective was to evaluate the role of endogenous activated Ang-(1-7) during atherosclerosis. In mice, the effects of endogenous Ang-(1-7) on atherogenesis in early stage and plaque stability in late stage were observed in ApoE knockout (ApoE-/-) mice fed with a high fat diet. Blockage of endogenous Ang-(1-7) with A779, an Ang-(1-7) antagonist, did not increase early plaque lesion formation, however, it remarkably enhanced contents of lipids and macrophages and decreased contents of vascular smooth muscle cells (VSMCs) and collagens in late lesions. The expressions of proinflammatory cytokines, and the expressions and activities of matrix metalloproteinases were significantly elevated in A779-treated group than those in vehicle-treated group in late lesions. Exogenous Ang-(1-7) treatment attenuated early atherosclerotic plaque formation and enhanced late plaques stability in this model. The contents of Ang-II and Ang-(1-7) and activity of ACE2 in late atherosclerotic plaques were higher than those of early atherosclerotic lesions. Endogenous activated Ang-(1-7...Continue Reading
References
May 1, 1994·Circulation·H C StaryR W Wissler
Jun 17, 2000·Atherosclerosis·G PasterkampC Borst
Mar 24, 2004·Circulation·Francesco CipolloneAndrea Mezzetti
Jul 28, 2004·Circulation·Sven WassmannGeorg Nickenig
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
Jul 29, 2005·Experimental Physiology·Matthew J HuentelmanMohan K Raizada
Jan 18, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Justin L GrobeMichael J Katovich
Apr 10, 2007·Lancet·Roland E SchmiederBernhard M W Schmidt
Jul 10, 2007·Lancet·Martin H Strauss, Alistair Hall
Dec 21, 2007·Atherosclerosis·Erwin BlessingFlorian Bea
May 24, 2008·The Journal of Pathology·J C SluimerS Heeneman
Jul 29, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Fina LovrenSubodh Verma
Aug 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Cheng ZhangYihai Cao
Jul 20, 2011·Journal of Cellular Physiology·Laura L Souza, Claudio M Costa-Neto
Jan 5, 2014·Circulation Research·Carlos Silvestre-RoigOliver Soehnlein
Apr 30, 2014·Nature Reviews. Cardiology·Fan JiangCheng Zhang
Citations
Jul 28, 2015·Trends in Cardiovascular Medicine·Xiao Yu TianWing Tak Wong
Aug 9, 2016·Vascular Pharmacology·Ali NehmeKazem Zibara
Oct 19, 2016·Hypertension·Ali NehmeKazem Zibara
Oct 10, 2018·American Journal of Physiology. Endocrinology and Metabolism·Justin LoloiAmy C Arnold
May 19, 2019·Clinical Science·Yu SunJianmin Yang
May 5, 2018·Journal of Cardiovascular Development and Disease·Shutan Liao, Craig S McLachlan
Jul 31, 2019·Heart and Vessels·Xiaomin ZhouHuimin Yu
Oct 6, 2020·Frontiers in Physiology·Gabriela M SilvaThyago M Queiroz
Mar 22, 2019·Nature Reviews. Cardiology·Laura CalvilloGianfranco Parati
Jul 20, 2016·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Wenjing LiJianmin Yang
Mar 12, 2021·Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia·Bárbara Caroline Dias FariaAna Cristina Simões E Silva
Jun 11, 2017·Atherosclerosis·Ali Nehme, Kazem Zibara
Nov 21, 2018·Developmental and Comparative Immunology·Mei JiangLin Tang
Aug 22, 2021·Molecular Biology Reports·Fernanda Rocha Chaves MoreiraAna Cristina Simões E Silva